1. 254PMatching-adjusted indirect treatment comparison of ribociclib and palbociclib as first-line treatments for HR+, HER2– ABC. (18th September 2017) Authors: Forsythe, A.; Chandiwana, D.; Dolph, M.; Tremblay, G.; Monaco, M. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009–15. (13th February 2017) Authors: Boikos, C.; Caya, C.; Doll, M. K.; Kraicer-Melamed, H.; Dolph, M.; Delisle, G.; Winters, N.; Gore, G.; Quach, C. Journal: Journal of antimicrobial chemotherapy Issue: Volume 72:Number 6(2017:Jun.) Page Start: 1556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗